Amniotic Fluid Embolism: Insights from Chinese Expert Consensus on Diagnosis and Care
Amniotic fluid embolism (AFE) is a rare but life-altering condition that strikes suddenly during or after childbirth, with a maternal mortality rate ranging from 19% to 86%. While it affects just 7.7 out of every 100,000 births in the U.S., its unpredictability makes understanding its signs and care critical for protecting new mothers. In 2018, the Obstetrics Group of the Chinese Society of Obstetrics and Gynecology released a consensus on AFE diagnosis and management—built on the 2016 Society for Maternal-Fetal Medicine (SMFM) guidelines—to standardize care and improve outcomes. Ye Feng and Hui-Xia Yang from Peking University First Hospital and the Beijing Key Laboratory of Maternal Fetal Medicine of Gestational Diabetes Mellitus interpreted this consensus in the Chinese Medical Journal in 2020, offering clear, evidence-based guidance for clinicians and families.
What Is AFE?
AFE occurs when amniotic fluid— the protective liquid surrounding a fetus—enters the mother’s bloodstream. This happens if the “maternal-fetal barrier” (e.g., the placenta or uterine lining) is damaged during labor, delivery, or procedures like induced abortion or amniocentesis. The fluid triggers two dangerous processes:
- Mechanical obstruction: Amniotic fluid particles block small blood vessels.
- Immune reaction: Fluid components activate the mother’s immune system (including the complement system), leading to systemic inflammation, respiratory failure, and heart failure.
The result? A cascade of life-threatening symptoms: sudden shortness of breath, low blood pressure, and uncontrollable bleeding.
Who Is at Risk?
AFE most often occurs:
- During labor (70% of cases)
- After vaginal delivery (11%)
- During cesarean section (19%)
In China, a 2011 study of 111,767 hospital cases found a higher incidence (6 per 10,000 births)—likely due to stricter diagnostic criteria and the focus on high-risk patients in tertiary/secondary hospitals. Rare cases have been linked to induced abortion, transabdominal amnioinfusion, or cervical suture removal.
How Is AFE Diagnosed?
AFE is a clinical diagnosis—no single lab test can confirm it. Doctors use five key criteria:
- Acute hypotension or cardiac arrest (sudden low blood pressure or heart stoppage).
- Acute hypoxemia (symptoms like shortness of breath, blue lips, or respiratory arrest).
- Coagulopathy (unexplained severe bleeding or lab evidence of clotting factor loss).
- Timing (symptoms start during labor, cesarean section, or within 30 minutes of delivery).
- No other explanation (ruling out conditions like postpartum hemorrhage or heart failure).
Doctors also suspect AFE if a mother has sudden respiratory/circulatory failure with prodromal symptoms (early warnings) like anxiety, cough, or fetal distress (e.g., severe bradycardia—slow fetal heart rate).
What Are the Warning Signs?
AFE often starts with subtle “prodromes” (30% to 40% of patients):
- Shortness of breath, cough, or chest pain
- Nausea, vomiting, or anxiety
- Irritability or confusion
For unborn babies, severe bradycardia (a heart rate below 110 beats per minute) may be the first sign of AFE. If these symptoms appear, act fast—AFE can progress to respiratory failure, shock, or cardiac arrest within minutes.
How Is AFE Treated?
Care focuses on supporting vital functions (breathing, circulation, clotting) and delivering the baby if viable. Here’s what clinicians prioritize:
1. Respiratory Support
Keep the airway open and provide oxygen or mechanical ventilation to prevent hypoxia (low oxygen) and hypercapnia (high carbon dioxide)—both worsen heart failure.
2. Circulatory Support
- CPR first: If cardiac arrest occurs, start chest compressions before breathing support. For pregnant women, tilt to the left or displace the uterus to avoid compressing the aorta (main blood vessel).
- Fluid caution: Too much fluid causes pulmonary edema (fluid in lungs) or right heart failure—use only what’s necessary.
- Vasopressors/inotropes: Drugs like dobutamine and milrinone improve heart function and relax pulmonary blood vessels (reducing strain). The Chinese consensus adds papaverine for low-resource settings.
- Advanced support: For unresponsive shock, extracorporeal membrane oxygenation (ECMO) or intra-aortic balloon pumps can keep blood flowing.
3. Fetal Delivery
If the baby is ≥23 weeks (viable) and the mother has cardiac arrest, deliver within 4 minutes of CPR to reduce fetal hypoxia. This may mean an emergency cesarean section.
4. Bleeding and Coagulopathy
AFE causes disseminated intravascular coagulation (DIC)—the body uses up all clotting factors, leading to uncontrolled bleeding. Treatment includes:
- Massive transfusion: Fresh frozen plasma, platelets, and fibrinogen to replace lost factors.
- Tranexamic acid: An anti-fibrinolytic drug to stop excessive bleeding.
- No heparin: Unless there’s early evidence of dangerous blood clots (hypercoagulability).
5. Obstetric Care
Uterine atony (weak contractions) is common. Use uterotonics (e.g., oxytocin) to stimulate contractions. For severe bleeding, try uterine tamponade (balloon), artery ligation, or B-Lynch sutures. Hysterectomy is only a last resort to save the mother’s life.
6. Organ Protection
After resuscitation, AFE can lead to kidney failure, acute respiratory distress syndrome (ARDS), or brain damage from hypoxia. Doctors monitor vital signs closely, maintain electrolyte balance, and use hypothermia (cooling) if needed to protect the brain.
Key Takeaways
- AFE is diagnosed by exclusion: No lab test confirms it—rely on symptoms and timing.
- Early action saves lives: Prodromal symptoms (e.g., anxiety, cough) and fetal bradycardia are red flags.
- Multidisciplinary care is non-negotiable: Anesthesia, critical care, and obstetrics teams must work together.
- Mortality is falling: Better recognition and supportive care have cut AFE-related deaths in recent years.
Sources
This guidance is based on the 2018 Chinese Expert Consensus on AFE Diagnosis and Management (Chinese Society of Obstetrics and Gynecology) and the 2016 SMFM Guideline on AFE. Key studies include population-based research from the U.S. and China, and clinical reviews on AFE pathophysiology.
For the full interpretation:
Feng Y, Yang HX. Interpretation of Chinese expert consensus on diagnosis and management of amniotic fluid embolism. Chinese Medical Journal 2020;133:1719–1721. doi:10.1097/CM9.0000000000000886
Was this helpful?
0 / 0